Specifications:
Item Type: Targeted therapy (IDH2 inhibitor)
Also Known As: Oral tablet, once daily
Storage: enasideniboC
Condition: New
Notable Specs & Safety: Differentiation syndrome risk; requires IDH2 mutation confirmation
Product Code: PDC-MED-208913
Ratings:
Views:
Product Description:
Idhifa (enasidenib) is a targeted therapy for adults with relapsed or refractory AML with an IDH2 mutation. It helps reduce the oncometabolite 2 HG, supporting healthier blood formation. Your care team will monitor labs closely during treatment.
Why Choose Us
Quality
You can TrustOntime
GuaranteeCheap
DeliveryReturn Policy
GuaranteedDelivery Options & Overview
1. Order the Product and Specify the Delivery Method
2. You will receive an Order Confirmation Message
3. Pay & Wait for arrival Notification by call or email
4. Product is delivered to your address
Shop by Category
Partners
